免费加速器苹果

免费加速器苹果

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

免费加速器苹果

Learn More
Folded page of a newspaper

免费加速器苹果

免费加速器苹果

Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results

免费加速器苹果

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

免费加速器苹果

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

免费加速器苹果

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

免费加速器苹果

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

免费加速器苹果

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

bannana加速器vp  极光vp n官方  老王v屁恩破解版  极光加速器最新  佛跳墙官方首页极光  super vnp  vmp官网